HQL Pharmaceuticals is a biotech company focused on Drug Discovery, based in Rehovot, Israel. The company was established in 2009 with a goal to exploit commercial opportunities of an extremely powerful new computing platform, called "CSS".
Our mission is to transform Drug Discovery into a computationally driven, highly efficient process, yielding a large diversity of high quality drug candidates, and addressing the toughest scientific challenges. These include but are not limited to: scaffold hopping, antagonizing protein-protein interactions, hitting two targets at the same time, and transforming fragment hits into viable drug candidates.Read more...
Viva Biotech and HQL Pharmaceuticals Join Forces to Form Powerhouse for Structure - and Fragment - Based Drug Discovery
GalChimia signs deal with HQL Pharmaceuticals
Super Molecule representing 1018 chemical entites